Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTUITIVE SURGICAL INCISRG · Entity 2878 | EVP & Chief Strategy & Corp Op | April 25, 2025 | April 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTUITIVE SURGICAL INC
Report date April 25, 2025 · Filed April 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,224 |
Ending reported balance
After 2025-04-29 transaction · row 12
12 source rows · reconciled sequenceRow 1 · 2025-04-25 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 2 · 2025-04-25 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 3 · 2025-04-25 · Exercise / conversion · Acquired 119 · Balance 5,343 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 4 · 2025-04-25 · Sale · Disposed 119 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 5 · 2025-04-25 · Exercise / conversion · Acquired 119 · Balance 5,343 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 6 · 2025-04-25 · Sale · Disposed 119 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 7 · 2025-04-25 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 8 · 2025-04-25 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 9 · 2025-04-28 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 10 · 2025-04-28 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 11 · 2025-04-29 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 12 · 2025-04-29 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.90 · Expires 2029-08-28 | Direct | 2,068 |
Reported balance
After 2025-04-25 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2025-04-25 · Exercise / conversion · Disposed 188 · Balance 2,068 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.90 · Expires 2029-08-28 | Direct | 1,880 |
Reported balance
After 2025-04-29 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-04-29 · Exercise / conversion · Disposed 188 · Balance 1,880 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $229.39 · Expires 2030-02-27 | Direct | 2,634 |
Reported balance
After 2025-04-25 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-04-25 · Exercise / conversion · Disposed 119 · Balance 2,634 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F3: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $290.33 · Expires 2029-02-28 | Direct | 2,068 |
Reported balance
After 2025-04-25 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-04-25 · Exercise / conversion · Disposed 188 · Balance 2,068 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $290.33 · Expires 2029-02-28 | Direct | 1,880 |
Reported balance
After 2025-04-28 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-04-28 · Exercise / conversion · Disposed 188 · Balance 1,880 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $304.67 · Expires 2030-08-09 | Direct | 2,634 |
Reported balance
After 2025-04-25 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-04-25 · Exercise / conversion · Disposed 119 · Balance 2,634 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F5: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025.
F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F3: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F5: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 422 | $539.10 | $227,500.20 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 484 | $967.21 | $468,129.16 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,978 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 484 | $727.01 | $351,872.84 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:02 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 725 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000044 · edgardoc.xml · derivative · entry 4 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,174 Underlying: Common Stock · 725 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:02 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 286 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000044 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,978 F1 · kind: RSUs convert into common stock on the vest date on a one-for-one basis. On the transaction date, 25% of the shares were released and a portion of the shares were held back to cover the statutory tax withholding requirement. The net shares were deposited into the holders account. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:02 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000044 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs convert into common stock on the vest date on a one-for-one basis. On the transaction date, 25% of the shares were released and a portion of the shares were held back to cover the statutory tax withholding requirement. The net shares were deposited into the holders account. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 19:02 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 2,118 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000044 · edgardoc.xml · derivative · entry 5 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,118 Underlying: Common Stock · 2,118 shares Expires 2025-02-26 F3 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 19:02 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,177 | $0.00 Strike: $736.80 | $0.00 |
DisclosureSEC source: 0001035267-21-000044 · edgardoc.xml · derivative · entry 3 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,177 Underlying: Common Stock · 3,177 shares Expires 2031-02-26 F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| February 17, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 2,958 | $782.00 | $2,313,156.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · nonDerivative · entry 7 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,539 F2 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 708 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · derivative · entry 10 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,416 Underlying: Common Stock · 708 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 958 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · derivative · entry 9 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958 Underlying: Common Stock · 958 shares Expires 2022-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 1,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · derivative · entry 8 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 591 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · nonDerivative · entry 6 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,497 F1 · kind: RSUs convert into common stock on the vest date on a one-for-one basis. On the transaction date, 25% of the shares were released and a portion of the shares were held back to cover the statutory tax withholding requirement. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs convert into common stock on the vest date on a one-for-one basis. On the transaction date, 25% of the shares were released and a portion of the shares were held back to cover the statutory tax withholding requirement. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 294 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,588 F1 · kind: RSUs convert into common stock on the vest date on a one-for-one basis. On the transaction date, 25% of the shares were released and a portion of the shares were held back to cover the statutory tax withholding requirement. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 958 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs convert into common stock on the vest date on a one-for-one basis. On the transaction date, 25% of the shares were released and a portion of the shares were held back to cover the statutory tax withholding requirement. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 178 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,924 F1 · kind: RSUs convert into common stock on the vest date on a one-for-one basis. On the transaction date, 25% of the shares were released and a portion of the shares were held back to cover the statutory tax withholding requirement. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 23:53 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000040 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs convert into common stock on the vest date on a one-for-one basis. On the transaction date, 25% of the shares were released and a portion of the shares were held back to cover the statutory tax withholding requirement. The net shares were deposited into the holders account. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 16:06 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,449 | $0.00 Strike: $727.01 | $0.00 |
DisclosureSEC source: 0001035267-20-000154 · edgardoc.xml · derivative · entry 1 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,449 Underlying: Common Stock · 1,449 shares Expires 2030-08-28 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 382 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · derivative · entry 7 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 382 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The exercise price to the shares underlying this grant is $230.9967, equal to 100% of the closing FMV of the Company on the date of grant. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 383 | $0.00 Strike: $178.39 | $0.00 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 383 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 383 | $665.57 | $254,912.77 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,348 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F3 · price: The average selling price for the transaction was $665.568628. The shares sold at $663.08-$663.42 = 400 shares;$665.13 = 12 shares;$666.66 = 100 shares; $667.65 - $667.65 = 100 shares; 668.98 = 100 shares; $670.44 - $670.47 = 53 shares. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 383 | $178.39 | $68,322.11 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 382 | $665.57 | $254,247.21 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,348 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F3 · price: The average selling price for the transaction was $665.568628. The shares sold at $663.08-$663.42 = 400 shares;$665.13 = 12 shares;$666.66 = 100 shares; $667.65 - $667.65 = 100 shares; 668.98 = 100 shares; $670.44 - $670.47 = 53 shares. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 382 | $231.00 | $88,240.74 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,033 | $666.69 | $688,687.88 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,348 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F2 · price: The average selling price for the transaction was $666.687162. The shares sold at $663.33-$663.42 = 300 shares; $664.75 - $664.84 = 200 shares; $665.13 = 17 shares; $667.65 = 100 shares; $668 = 100 shares; $670.133 - $670.65 = 316 shares. Read SEC document |
| May 11, 2020 Filed May 12, 2020 23:22 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 483 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-20-000091 · edgardoc.xml · derivative · entry 2 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483 Underlying: Common Stock · 483 shares Expires 2024-05-11 F2 · derivative.exercise_date: Each Restricted Stock Unit, granted pursuant to the 2010 Incentive Award Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period of time. Read SEC document |
| May 11, 2020 Filed May 12, 2020 23:22 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,448 | $0.00 Strike: $539.10 | $0.00 |
DisclosureSEC source: 0001035267-20-000091 · edgardoc.xml · derivative · entry 1 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448 Underlying: Common Stock · 1,448 shares Expires 2030-05-11 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.